Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hycos Reparador EB topical single-arm study in epidermolysis bullosa
RBR-7kc6rrxCompleted
- Sponsor
- Instituto de Saúde e Bem Estar da Mulher
- Start
- Jan 2024
- Countries
- 1
01
Overview
Single-blind, single-arm trial in epidermolysis bullosa (EB) and wound healing, sponsored by Instituto de Saúde e Bem Estar da Mulher. Primary endpoint: Effectiveness and safety of Hycos Reparador EB. Started Jan 2024; status: completed.
02
Conditions
epidermolysis bullosa (EB)wound healing
Beyond the preview
Go deeper on RBR-7kc6rrx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7kc6rrx.